Cardiac Science to present at Needham Biotechnology and Medical Technology Conference

Bothell’s Cardiac Science Corporation, a global leader in advanced cardiac diagnosis, resuscitation, rehabilitation and informatics products, announced that it will present at the seventh annual Needham and Company Biotechnology and Medical Technology Conference at the New York Palace Hotel. Michael Matysik, senior vice president and chief financial officer, will review the company’s business strategy and recent financial results during the company’s presentation at 11:30 a.m. June 12.

Cardiac Science will offer a live Web cast of its presentation, which may be accessed at the company’s Web site at http://www.cardiacscience.com/. An archived replay of the presentation will also be available following the live presentation and can be accessed at http://www.cardiacscience.com/ for 90 days.